Brainomix is a neurotechnology company building advanced imaging software that applies artificial intelligence to the analysis of brain CT and MRI scans. The company operates at the intersection of neuroimaging and clinical decision support, focusing on time-critical neurological conditions.

Its core platform uses machine learning algorithms to automatically quantify imaging biomarkers such as ischemic core, penumbra, and white-matter changes. The software standardizes interpretation across sites, reduces inter-rater variability, and integrates directly into existing radiology and stroke care workflows.

Brainomix’s solutions are deployed in hospital and acute-care settings to support stroke triage, treatment selection, and outcome optimization. The company also positions its platform for use in research and pharmaceutical trials by enabling scalable, reproducible imaging analysis across large datasets.